Zai Lab Limited (HKG:9688)
14.88
+0.40 (2.76%)
Jan 21, 2026, 4:08 PM HKT
Zai Lab Market Cap
Zai Lab has a market cap or net worth of 16.4 billion as of January 20, 2026. Its market cap has decreased by -25.99% in one year.
Market Cap
16.40B
Enterprise Value
12.52B
Revenue
3.44B
Ranking
n/a
PE Ratio
n/a
Stock Price
14.88
Market Cap Chart
Since September 18, 2017, Zai Lab's market cap has increased from 1.36B to 16.40B, an increase of 1,107.10%. That is a compound annual growth rate of 34.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 16.12B | 5.55% |
| Dec 31, 2025 | 15.27B | -31.09% |
| Dec 31, 2024 | 22.16B | 5.54% |
| Dec 29, 2023 | 21.00B | -8.60% |
| Dec 30, 2022 | 22.97B | -51.38% |
| Dec 31, 2021 | 47.25B | -48.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 18, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InnoCare Pharma | 23.79B |
| Ascentage Pharma Group International | 18.73B |
| Keymed Biosciences | 17.56B |
| Guangzhou Innogen Pharmaceutical Group | 14.02B |
| Everest Medicines | 13.55B |
| Ascletis Pharma | 13.39B |
| Mirxes Holding Company | 11.61B |
| HBM Holdings | 10.81B |